CD160-Associated CD8 T-Cell Functional Impairment Is Independent of PD-1 Expression

English version České info

T-cell immune response is regulated by a variety of molecules known as co-inhibitory receptors. The over expression of co-inhibitory receptors has been observed in several chronic viral infections such as HIV disease, and is found to be associated with severe T-cell dysfunction. Recent studies have demonstrated that the co-expression of several co-inhibitory receptors correlated with greater impairment of CD8 T cells. However, the relative contribution of individual co-inhibitory receptors to the regulation of T-cell functions remains unclear. In order to shed light on these issues, we have evaluated the influence of the expression of 3 major co-inhibitory receptors such as PD-1, 2B4 and CD160 on CD8 T-cell functions such as proliferation, cytokines production and expression of cytotoxic granules. We demonstrate that CD160-associated CD8 T-cell functional impairment is independent of PD-1 expression and that the blockade of CD160 signaling may partially restore CD8 T-cell functions.

Vyšlo v časopise: CD160-Associated CD8 T-Cell Functional Impairment Is Independent of PD-1 Expression. PLoS Pathog 10(9): e32767. doi:10.1371/journal.ppat.1004380
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004380

Souhrn

Zdroje

1. LenschowDJ, BluestoneJA (1993) T cell co-stimulation and in vivo tolerance. Curr Opin Immunol 5: 747–752.

2. ViganoS, PerreauM, PantaleoG, HarariA (2012) Positive and negative regulation of cellular immune responses in physiologic conditions and diseases. Clin Dev Immunol 2012: 485781.

3. LeibsonPJ (2004) The regulation of lymphocyte activation by inhibitory receptors. Curr Opin Immunol 16: 328–336.

4. ChenL (2004) Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nature reviews Immunology 4: 336–347.

5. CaiG, FreemanGJ (2009) The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol Rev 229: 244–258.

6. CannonsJL, TangyeSG, SchwartzbergPL (2011) SLAM family receptors and SAP adaptors in immunity. Annu Rev Immunol 29: 665–705.

7. CarrenoBM, CollinsM (2002) The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 20: 29–53.

8. KhaitanA, UnutmazD (2011) Revisiting immune exhaustion during HIV infection. Curr HIV/AIDS Rep 8: 4–11.

9. LenschowDJ, WalunasTL, BluestoneJA (1996) CD28/B7 system of T cell costimulation. Annu Rev Immunol 14: 233–258.

10. WattsTH (2005) TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23: 23–68.

11. DayCL, KaufmannDE, KiepielaP, BrownJA, MoodleyES, et al. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350–354.

12. PetrovasC, CasazzaJP, BrenchleyJM, PriceDA, GostickE, et al. (2006) PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 203: 2281–2292.

13. TrautmannL, JanbazianL, ChomontN, SaidEA, GimmigS, et al. (2006) Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 12: 1198–1202.

14. McMahanRH, Golden-MasonL, NishimuraMI, McMahonBJ, KemperM, et al. (2010) Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 120: 4546–4557.

15. WherryEJ, AhmedR (2004) Memory CD8 T-cell differentiation during viral infection. J Virol 78: 5535–5545.

16. WherryEJ, BlattmanJN, Murali-KrishnaK, van der MostR, AhmedR (2003) Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77: 4911–4927.

17. YamamotoT, PriceDA, CasazzaJP, FerrariG, NasonM, et al. (2011) Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection. Blood 117: 4805–4815.

18. PeretzY, HeZ, ShiY, Yassine-DiabB, GouletJP, et al. (2012) CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction. PLoS Pathog 8: e1002840.

19. ViganoS, Bellutti EndersF, MiconnetI, CelleraiC, SavoyeAL, et al. (2013) Rapid Perturbation in Viremia Levels Drives Increases in Functional Avidity of HIV-specific CD8 T Cells. PLoS Pathog 9: e1003423.

20. BarberDL, WherryEJ, MasopustD, ZhuB, AllisonJP, et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682–687.

21. MakedonasG, HutnickN, HaneyD, AmickAC, GardnerJ, et al. (2010) Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathog 6: e1000798.

22. LegatA, SpeiserDE, PircherH, ZehnD, Fuertes MarracoSA (2013) Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than “Exhaustion” of Human CD8 T Cells. Front Immunol 4: 455.

23. HarariA, EndersFB, CelleraiC, BartPA, PantaleoG (2009) Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure. J Virol 83: 2862–2871.

24. CelleraiC, PerreauM, RozotV, EndersFB, PantaleoG, et al. (2010) Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression. Journal of virology 84: 3868–3878.

25. SpeiserDE, ColonnaM, AyyoubM, CellaM, PittetMJ, et al. (2001) The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells. J Immunol 167: 6165–6170.

26. PetrovasC, ChaonB, AmbrozakDR, PriceDA, MelenhorstJJ, et al. (2009) Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol 183: 1120–1132.

27. NishimuraH, AgataY, KawasakiA, SatoM, ImamuraS, et al. (1996) Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes. Int Immunol 8: 773–780.

28. BengschB, SeigelB, RuhlM, TimmJ, KuntzM, et al. (2010) Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 6: e1000947.

29. CaiG, AnumanthanA, BrownJA, GreenfieldEA, ZhuB, et al. (2008) CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol 9: 176–185.

30. AgrawalS, MarquetJ, FreemanGJ, TawabA, BouteillerPL, et al. (1999) Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol 162: 1223–1226.

31. BarakonyiA, RabotM, Marie-CardineA, Aguerre-GirrM, PolgarB, et al. (2004) Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset. J Immunol 173: 5349–5354.

32. Le BouteillerP, TabiascoJ, PolgarB, KozmaN, GiustinianiJ, et al. (2011) CD160: a unique activating NK cell receptor. Immunol Lett 138: 93–96.

33. AnumanthanA, BensussanA, BoumsellL, ChristAD, BlumbergRS, et al. (1998) Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol 161: 2780–2790.

34. GiustinianiJ, BensussanA, Marie-CardineA (2009) Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation. J Immunol 182: 63–71.

35. ChabotS, Jabrane-FerratN, BigotK, TabiascoJ, ProvostA, et al. (2011) A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor. J Exp Med 208: 973–986.

36. del RioML, LucasCL, BuhlerL, RayatG, Rodriguez-BarbosaJI (2010) HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation. Journal of leukocyte biology 87: 223–235.

37. RabotM, El CostaH, PolgarB, Marie-CardineA, Aguerre-GirrM, et al. (2007) CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment. Int Immunol 19: 401–409.

38. LiuFT, GiustinianiJ, FarrenT, JiaL, BensussanA, et al. (2010) CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia. Blood 115: 3079–3088.

39. HarariA, CelleraiC, EndersFB, KostlerJ, CodarriL, et al. (2007) Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proc Natl Acad Sci U S A 104: 16233–16238.

40. PerreauM, MennechetF, SerratriceN, GlasgowJN, CurielDT, et al. (2007) Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy. J Virol 81: 3272–3284.

41. PerreauM, WellesHC, HarariA, HallO, MartinR, et al. (2011) DNA/NYVAC Vaccine Regimen Induces HIV-Specific CD4 and CD8 T-Cell responses in Intestinal Mucosa. Journal of virology 85 (19) 9854–62..

42. PerreauM, WellesHC, HarariA, CalandraT, RogerT, et al. (2011) Modulation of human memory T-cell function by different antigen-presenting cells. Eur J Immunol 42 (3) 799–802.

43. RoedererM, NozziJL, NasonMC (2011) SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry Part A: the journal of the International Society for Analytical Cytology 79: 167–174.